|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$191,186
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
$78,102
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$70,600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$67,654
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$61,660
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
Cancer Center Support Grant
|
5P30CA068485-22
|
$5,853,094
|
$175,593
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-43
|
$5,815,389
|
$174,462
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Cancer Center Support Grant
|
5P30CA091842-16
|
$4,305,712
|
$43,057
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
5P30CA016056-40
|
$4,052,483
|
$40,525
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Childhood Cancer Survivor Study
|
2U24CA055727-23
|
$3,616,741
|
$1,808,371
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA077598-19
|
$3,561,178
|
$71,224
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA
|
|
Genomics of Acute Myelogenous Leukemia
|
5P01CA101937-14
|
$2,917,422
|
$320,916
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
DF/HCC SPORE in Prostate Cancer
|
5P50CA090381-15
|
$2,300,000
|
$943,000
|
LODA, MASSIMO
|
DANA-FARBER CANCER INST
|
|
Mayo Clinic SPORE in Pancreatic Cancer
|
5P50CA102701-14
|
$2,300,000
|
$2,300,000
|
PETERSEN, GLORIA
|
MAYO CLINIC ROCHESTER
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
5P50CA159981-05
|
$2,300,000
|
$253,000
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
SPORE: Brain Tumore SPORE Grant
|
5P50CA097257-15
|
$2,300,000
|
$460,000
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA042014-28
|
$2,284,983
|
$91,399
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-24
|
$2,258,441
|
$45,169
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-13
|
$2,246,011
|
$179,681
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Cancer Therapy & Research Center at UTHSCSA
|
5P30CA054174-23
|
$2,093,000
|
$41,860
|
MESA, RUBEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
NK cells, their receptors, transplantation and cancer therapy
|
5P01CA111412-12
|
$1,842,904
|
$552,871
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-14
|
$1,731,544
|
$865,772
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Genetics of Prostate Cancer in Africa
|
5U01CA184374-03
|
$1,707,746
|
$1,707,746
|
REBBECK, TIMOTHY
|
DANA-FARBER CANCER INST
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$28,286
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Great Lakes New England Clinical Validation Center
|
5U01CA086400-17
|
$1,315,798
|
$263,160
|
BRENNER, DEAN
|
UNIVERSITY OF MICHIGAN
|
|
Georgia NCI Community Oncology Research Program (NCORP)
|
5UG1CA189997-04
|
$1,304,055
|
$652,028
|
CANTUARIA, GUILHERME
|
NORTHSIDE HOSPITAL ATLANTA
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-04
|
$1,263,145
|
$1,263,145
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
MMC, VICC, & TSU: PARTNERS IN ELIMINATING CANCER DISPARITIES (2 of 3)
|
5U54CA163072-08
|
$1,233,813
|
$49,353
|
MOSES, HAROLD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Genetic Modifiers of Initiation and Progression of Mammary Cancer
|
ZIA BC 011255
|
$1,232,548
|
$123,255
|
Hunter, Kent
|
CCR (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,059,524
|
$529,762
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (3 of 3)
|
5U54CA163066-07
|
$804,096
|
$16,082
|
HUSAINI, BAQAR
|
TENNESSEE STATE UNIVERSITY
|
|
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas
|
5R01CA184585-04
|
$802,610
|
$401,305
|
NEUHAUSEN, SUSAN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Comparison of 3 Modes of Genetic Counseling in High-Risk Public Hospital Patients
|
5R01CA197784-02
|
$751,892
|
$751,892
|
PASICK, RENA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-43S3
|
$749,911
|
$22,497
|
DIASIO, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
Molecular signatures for liver cancer diagnosis and treatment stratification
|
ZIA BC 010313
|
$728,028
|
$218,408
|
Wang, Xin Wei
|
CCR (NCI)
|
|
Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients
|
5R01CA172743-05
|
$678,656
|
$339,328
|
SUTPHEN, REBECCA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Colorectal cancer risk loci: GWAS, fine-mapping, and functional analysis
|
5R01CA188214-05
|
$637,418
|
$637,418
|
ZHENG, WEI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors
|
1R01CA211625-01
|
$629,227
|
$629,227
|
KINNEY, ANITA
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-10
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Common and rare sequence variants in breast cancer risk
|
2R01CA121245-06A1
|
$585,500
|
$585,500
|
TAVTIGIAN, SEAN
|
UNIVERSITY OF UTAH
|
|
Molecular Predictive Testing in Ocular Melanoma
|
2R01CA125970-11
|
$561,808
|
$561,808
|
HARBOUR, JAMES
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Leveraging DNA damage repair pathways as therapeutic targets in women's cancers
|
ZIA BC 011525
|
$535,337
|
$53,534
|
Lee, Jung-Min
|
CCR (NCI)
|
|
BRCA1 and BRCA2 missense mutations and breast cancer risk
|
5U01CA116167-10
|
$527,128
|
$527,128
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$519,415
|
$103,883
|
Ambs, Stefan
|
CCR (NCI)
|
|
Methods for Integrating Functional Data into Complex Disease Genetic Analyses
|
5R01CA189532-03
|
$464,176
|
$464,176
|
HSU, LI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical and genetic studies in familial nonmedullary thyroid cancer (FNMTC)
|
ZIA BC 011287
|
$418,573
|
$209,286
|
Kebebew, Electron
|
CCR (NCI)
|
|
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
|
ZID BC 011792
|
$418,466
|
$83,693
|
Pack, Svetlana
|
CCR (NCI)
|
|
Functional Analysis of Human Breast Cancer Susceptibility Gene Variants
|
ZIA BC 011181
|
$410,928
|
$410,928
|
Sharan, Shyam
|
CCR (NCI)
|
Total relevant funding to Genetic Testing for this search: $25,304,806
|